Pulse Biosciences, Inc

(NASDAQ:PLSE)

Latest On Pulse Biosciences, Inc (PLSE):

Date/Time Type Description Signal Details
2023-05-11 23:32 ESTNewsPulse Biosciences GAAP EPS of -$0.26 misses by $0.04N/A
2023-05-11 23:32 ESTNewsPulse Biosciences, Inc. (PLSE) Q1 2023 Earnings Call TranscriptN/A
2023-05-10 19:26 ESTNewsPulse Biosciences to notify planned redemption of warrantsN/A
2023-05-03 14:17 ESTNewsPulse Biosciences appoints chief medical officerN/A
2023-05-01 12:51 ESTNewsPulse Biosciences up 7% on raising $65M from chairmanN/A
2023-03-31 09:03 ESTNewsPulse Biosciences GAAP EPS of -$0.25 misses by $0.01N/A
2023-03-31 09:03 ESTNewsPulse Biosciences Inc. (PLSE) Q4 2022 Earnings Call TranscriptN/A
2022-12-06 23:56 ESTNewsPulse Biosciences CFO Gardiner resignsN/A
2022-11-10 21:46 ESTNewsPulse Biosciences GAAP EPS of -$0.49N/A
2022-11-10 21:45 ESTNewsPulse Biosciences, Inc. (PLSE) Q3 2022 Earnings Call TranscriptN/A
2022-10-06 15:26 ESTNewsPulse Biosciences reports positive data on CellFX System for basal cell carcinoma lesionsN/A
2022-09-26 23:58 ESTNewsPulse Biosciences wins FDA clearance to expand use of CellFX SystemN/A
2022-09-20 20:50 ESTNewsPulse Biosciences appoints Kevin Danahy as CEO; Darrin Uecker to serve as CTON/A
2022-08-10 22:00 ESTNewsPulse Biosciences GAAP EPS of -$0.44 misses by $0.04, revenue of $0.26M misses by $0.18MN/A
2022-08-10 22:00 ESTNewsPulse Biosciences, Inc. (PLSE) CEO Darrin Uecker on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-04 15:23 ESTNewsPulse stock rises 9% as FDA clears added energy settings for use with skin treatment device CellFXN/A
2022-06-04 05:31 ESTNewsPulse Biosciences gives results for rights offeringN/A
2022-05-14 01:41 ESTNewsPulse Biosciences downgraded at Wainwright on strategy for CellFX skin deviceN/A
2022-05-12 03:29 ESTNewsPulse Biosciences GAAP EPS of -$0.58 misses by $0.06, revenue of $0.44M misses by $0.28MN/A
2022-05-12 03:29 ESTNewsPulse Biosciences, Inc. (PLSE) CEO Darrin Uecker on Q1 2022 Results - Earnings Call TranscriptN/A
2022-04-15 02:40 ESTNewsPulse Biosciences to launch rights offeringN/A
2022-04-02 03:11 ESTNewsPulse Bio reaches a historic low as H.C. Wainwright cuts target by over 50%N/A
2022-04-01 10:46 ESTNewsPulse Biosciences GAAP EPS of -$0.52 misses by $0.01, revenue of $0.84M beats by $0.03MN/A
2022-04-01 10:46 ESTNewsPulse Biosciences, Inc. (PLSE) CEO Darrin Uecker on Q4 2021 Results - Earnings Call TranscriptN/A
2022-02-08 23:01 ESTNewsPulse Biosciences falls 37% after FDA asks for more info on CellFX System label expansionN/A
2022-01-11 16:40 ESTNewsPulse biosciences expects preliminary 4Q and FY21 revenues below the consensusN/A
2021-11-16 06:10 ESTNewsPulse Biosciences EPS beats by $0.05, beats on revenueN/A
2021-11-16 06:10 ESTNewsPulse Biosciences, Inc. (PLSE) CEO Darrin Uecker on Q3 2021 Results - Earnings Call TranscriptN/A
2021-10-05 13:14 ESTNewsPulse Biosciences adds Laureen Debuono to its board of directorsN/A
2021-08-20 08:35 ESTNewsPulse Biosciences names Mitchell Levinson as chief strategy officerN/A
2021-08-10 09:47 ESTNewsPulse Biosciences EPS beats by $0.11N/A
2021-08-10 09:47 ESTNewsPulse Biosciences, Inc. (PLSE) CEO Darrin Uecker on Q2 2021 Results - Earnings Call TranscriptN/A
2021-07-21 19:41 ESTNewsPulse Biosciences gets Health Canada approval for CellFX SystemN/A
2021-07-21 19:29 ESTNewsPulse Biosciences to raise $50M via private placementN/A
2021-03-12 04:28 ESTAnalyst RatingThe Analyst Target Price has decreased from $46 to $43.Neutral
2021-02-24 04:28 ESTFinancialsCompany financials have been released.Neutral
2021-02-23 19:16 ESTNewsPulse Biosciences (PLSE) Investor Presentation - SlideshowN/A
2021-02-23 01:32 ESTNewsPulse Biosciences EPS misses by $0.09N/A
2021-02-23 01:31 ESTNewsPulse Biosciences, Inc. (PLSE) CEO Darrin Uecker on Q4 2020 Results - Earnings Call TranscriptN/A
2021-02-23 00:30 ESTEarnings EstimateAn EPS average of $0.35 is estimated for the 2022 year.Buy
2021-02-23 00:30 ESTEarnings EstimateAn EPS average of -$0.48 is estimated for the quarter ending on June 30, 2021.Buy
2021-02-05 12:12 ESTAnalyst RatingThe Analyst Target Price has increased from $40 to $46.Buy
2021-02-04 19:34 ESTNewsPulse Biosciences establishes at-the-market equity programN/A
2021-01-27 12:28 ESTAnalyst RatingThe Analyst Target Price has increased from $16 to $40.Buy
2021-01-25 21:00 ESTNewsPulse Biosciences gains on Europe approval for CellFX systemN/A
2021-01-13 02:53 ESTNewsPulse Biosciences' CellFX System U.S. application moves forward for general dermatology indicationN/A
2020-11-26 21:14 ESTFinancialsCompany financials have been released.Neutral
2020-11-11 04:43 ESTFinancialsCompany financials have been released.Neutral
2020-11-10 22:20 ESTNewsPulse Biosciences, Inc. (PLSE) CEO Darrin Uecker on Q3 2020 Results - Earnings Call TranscriptN/A
2020-11-10 12:52 ESTEarnings EstimateAn EPS average of -$0.43 is estimated for the quarter ending on March 31, 2021.Buy

About Pulse Biosciences, Inc (PLSE):

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It engages in the research and development, and commercialization of CellFX system that provides a precise and non-thermal cellular treatment technology delivering nanosecond duration energy pulses that impact cells in treated tissue while sparing surrounding non-cellular tissue primarily for dermatology applications. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was founded in 2014 and is headquartered in Hayward, California.

PLSE Quotes by TradingView

See Advanced Chart

General

  • Name Pulse Biosciences, Inc
  • Symbol PLSE
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • Fiscal Year EndDecember
  • IPO Date2016-05-18
  • Gic SectorHealth Care
  • Gic GroupHealth Care Equipment & Services
  • Gic IndustryHealth Care Equipment & Supplies
  • Gic SubIndustryHealth Care Equipment
  • Web URLhttp://www.pulsebiosciences.com
View More

Valuation

  • Price/Book (Most Recent Quarter) 34.42
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$2.00
  • Next Year EPS Estimate -$0.79
  • Next Quarter EPS Estimate -$0.46
  • Return on Assets -75%
  • Return on Equity -186%
  • Earnings Per Share -$2.17
  • Revenue Per Share $0
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 655.3 million
  • EBITDA -40697000
  • PE Ratio -10.63
  • Analyst Target Price $43
  • Book Value Per Share $0.90
View More

Share Statistics

  • Shares Outstanding 26.09 million
  • Shares Float 11.93 million
  • % Held by Insiders 4965%
  • % Held by Institutions 11.68%
  • Shares Short 1.21 million
  • Shares Short Prior Month 1.12 million
  • Short Ratio 6.88
  • Short % of Float 7%
  • Short % of Shares Outstanding 5%
View More

Technicals

  • Beta 1.77
  • 52 Week High $45.82
  • 52 Week Low $5.59
  • 50 Day Moving Average 32.94
  • 200 Day Moving Average 20.8
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Pulse Biosciences, Inc (PLSE) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Pulse Biosciences, Inc (PLSE) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-22$N/A-$0.54-$0.45-20%
2020-09-302020-11-09$N/A-$0.51-$0.44-15.91%
2020-06-302020-08-10$N/A-$0.53-$0.50-6%
2020-03-312020-05-11$N/A-$0.57-$0.47-21.28%
2019-12-312020-03-16$N/A-$0.66-$0.61-8.2%
2019-09-302019-11-07$N/A-$0.57-$0.616.56%
2019-06-302019-08-08$N/A-$0.55-$0.51-7.84%
2019-03-312019-04-30$N/A-$0.49-$0.44-11.36%
2018-12-312019-02-07$N/A-$0.51
2018-09-302018-11-28$N/A-$0.64
2018-06-302018-07-31$N/A-$0.54
2018-03-312018-03-31$N/A-$0.51
2017-12-312018-03-16$N/A-$0.53
2017-09-302017-11-07$N/A-$0.52
2017-06-302017-07-27$N/A-$0.43
2017-03-312017-05-04$N/A-$0.23
2016-12-312017-03-14$N/A-$0.21
2016-09-302016-09-30$N/A-$0.21
2016-06-302016-06-30$N/A-$0.23

Pulse Biosciences, Inc (PLSE) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Research Development N/A N/A N/A 6.18 million 6.59 million
Income Before Tax N/A N/A N/A -11.87 million -13.79 million
Selling General Administrative N/A N/A N/A 5.6 million 7.17 million
Gross Profit N/A N/A N/A N/A N/A
Ebit N/A N/A N/A -11.68 million -13.93 million
Operating Income N/A N/A N/A -11.95 million -13.93 million
Income Tax Expense N/A N/A N/A N/A N/A
Total Revenue N/A N/A N/A N/A N/A
Cost of Revenue N/A N/A N/A N/A N/A
Total Other Income Expense Net N/A N/A N/A N/A 142000
Net Income From Continuing Operations N/A N/A N/A -11.87 million -13.79 million
Net Income Applicable to Common Shares -13.75 million -12.9 million -11.33 million N/A -13.79 million
Cash Flow:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Investments N/A N/A 10.32 million 6.49 million N/A
Change to Liabilities 163000 -9000 N/A 102000 N/A
Total Cash Flow from Investing Activities -22.57 million 8.08 million N/A 6.53 million N/A
Net Borrowings N/A N/A N/A N/A N/A
Total Cash Flow from Financial Activities N/A N/A 264000 N/A N/A
Change to Operating Activities 1.28 million 601000 N/A 735000 N/A
Change in Cash N/A N/A 965000 -2.67 million N/A
Total Cash from Operating Activities -8.55 million -7.94 million -9.62 million -9.2 million N/A
Depreciation N/A N/A 270000 270000 N/A
Other Cash Flow from Investing Activities N/A N/A N/A N/A N/A
Change to Inventory N/A N/A N/A N/A N/A
Change to Account Receivables N/A N/A N/A N/A N/A
Other Cash Flow from Financing Activities 501000 N/A N/A N/A N/A
Change to Net Income 2.64 million 2.53 million N/A 3.49 million N/A
Capital Expenditures N/A N/A 171000 37000 N/A
Balance Sheet:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Total Liabailities N/A N/A N/A 10.07 million 11.18 million
Total Stockholder Equity N/A N/A N/A 21.77 million 30.74 million
Other Current Liabilities N/A N/A N/A N/A 234000
Total Assets N/A N/A N/A 31.84 million 41.92 million
Common Stock 25000 25000 25000 N/A 21000
Other Current Assets N/A N/A N/A N/A N/A
Retained Earnings -172.54 million -158.79 million -145.89 million -134.56 million -122.69 million
Other Liabilities N/A N/A N/A N/A N/A
Other Assets 365000 365000 365000 N/A 494000
Cash N/A N/A N/A 7.86 million 6.9 million
Total Current Liabilities 7.59 million 6 million N/A 3.38 million 4.46 million
Other Stockholder Equity -1000 1000 N/A N/A 4000
Property, Plant & Equipment 11.92 million 12.16 million 12.34 million N/A 7.68 million
Total Current Assets 22.34 million 30.33 million N/A 16.43 million 26.4 million
Long Term Investments N/A N/A N/A N/A N/A
Net Tangible Assets 16.22 million 25.87 million 35.32 million N/A 23.4 million
Short Term Investments N/A N/A N/A 8.02 million 18.5 million
Long Term Debt N/A N/A N/A N/A N/A
Inventory N/A N/A N/A N/A N/A
Accounts Payable 1.72 million 1.43 million N/A 1.21 million 1.96 million

Pulse Biosciences, Inc (PLSE) Chart:

Pulse Biosciences, Inc (PLSE) News:

Below you will find a list of latest news for Pulse Biosciences, Inc (PLSE) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Pulse Biosciences, Inc (PLSE) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2024-05-172.54.9CALL0 1717.6TRUE00
2024-05-1751.9CALL0 145275.72TRUE00
2024-05-177.50.65CALL0 204429.92TRUE00
2024-05-17100.1CALL1 72108.8FALSE0.10
2024-05-1712.50.15CALL0 2500FALSE00
2024-05-17150.05CALL0 20FALSE00
2024-05-1717.50CALL0 00FALSE00
2024-05-17200CALL0 00FALSE00
2024-05-172.50PUT0 00FALSE00
2024-05-1750.4PUT0 200FALSE00
2024-05-177.51.1PUT0 15492.08FALSE00
2024-05-17103.83PUT0 64113.6TRUE00
2024-05-1712.50PUT0 0370.03TRUE00
2024-05-17150PUT0 0417.19TRUE00
2024-05-1717.50PUT0 0451.97TRUE00
2024-05-17200PUT0 0505.91TRUE00
2024-06-212.50CALL0 0445.93TRUE00
2024-06-2152.05CALL0 158.78TRUE00
2024-06-217.50.83CALL0 10115.26TRUE00
2024-06-21100.3CALL0 45111.18FALSE00
2024-06-2112.50CALL0 0118.11FALSE00
2024-06-21150CALL0 00FALSE00
2024-06-212.50PUT0 00FALSE00
2024-06-2150PUT0 0157.56FALSE00
2024-06-217.51.36PUT0 3217.02FALSE00
2024-06-21103.4PUT1 0159.04TRUE3.40
2024-06-2112.50PUT0 0229.44TRUE00
2024-06-21150PUT0 0238.13TRUE00
2024-07-192.56CALL0 16333.96TRUE00
2024-07-1952.65CALL0 614135.09TRUE00
2024-07-197.51.15CALL0 19183.89TRUE00
2024-07-19100.5CALL0 31296.11FALSE00
2024-07-1912.50.5CALL0 21891.34FALSE00
2024-07-19150.15CALL0 13990.07FALSE00
2024-07-1917.50.1CALL0 760FALSE00
2024-07-19200.42CALL0 2050FALSE00
2024-07-1922.50.13CALL0 440FALSE00
2024-07-19251.4CALL0 10FALSE00
2024-07-192.50.15PUT0 2000FALSE00
2024-07-1950.6PUT0 158129.89FALSE00
2024-07-197.51.9PUT0 71112.09FALSE00
2024-07-19103.6PUT0 368116.37TRUE00
2024-07-1912.54.2PUT0 24129.07TRUE00
2024-07-19157.2PUT0 1222.96TRUE00
2024-07-1917.58.3PUT0 3221.53TRUE00
2024-07-192011.4PUT0 2234.75TRUE00
2024-07-1922.513.7PUT0 3249.29TRUE00
2024-07-192518.5PUT0 346195.5TRUE00
2024-10-182.50CALL0 0216.9TRUE00
2024-10-1852.5CALL0 162163.35TRUE00
2024-10-187.51.35CALL0 2680TRUE00
2024-10-18100.95CALL200 43578.95FALSE0.950
2024-10-1812.50.85CALL0 23088.64FALSE00
2024-10-18150.35CALL0 2694.32FALSE00
2024-10-1817.51.45CALL0 4189.85FALSE00
2024-10-18200CALL0 00FALSE00
2024-10-182.50PUT0 00FALSE00
2024-10-1850PUT0 0117.3FALSE00
2024-10-187.50PUT0 0111.09FALSE00
2024-10-18104.3PUT0 45113.36TRUE00
2024-10-1812.55.1PUT0 10123.78TRUE00
2024-10-18150PUT0 0167.04TRUE00
2024-10-1817.511.3PUT0 1141.62TRUE00
2024-10-182013.8PUT0 294211.8TRUE00

Latest PLSE Trades:

Date Shares Price
Jun 13, 2022 7:58 PM EST43$2.11
Jun 13, 2022 7:58 PM EST26$2.12
Jun 13, 2022 7:58 PM EST3$2.12
Jun 13, 2022 7:59 PM EST32$2.135
Jun 13, 2022 7:59 PM EST220$2.135

Pulse Biosciences, Inc (PLSE) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1625101/000120919120038948/0001209191-20-038948-index.htm
2018-05-17UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1625101/000000000018015315/0000000000-18-015315-index.htm
2018-11-02UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1625101/000000000018034257/0000000000-18-034257-index.htm
2019-09-05UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1625101/000000000019013215/0000000000-19-013215-index.htm
2019-09-11UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1625101/000000000019013460/0000000000-19-013460-index.htm
2020-04-09UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1625101/000000000020003102/0000000000-20-003102-index.htm
2020-05-07UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1625101/000000000020004004/0000000000-20-004004-index.htm
2020-08-18UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1625101/000000000020007612/0000000000-20-007612-index.htm
2018-04-06SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1625101/000089914018000332/0000899140-18-000332-index.htm
2018-12-17SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1625101/000092189518003324/0000921895-18-003324-index.htm
2020-06-17SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1625101/000092189520001796/0000921895-20-001796-index.htm
2018-10-25S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1625101/000114036118041280/0001140361-18-041280-index.htm
2018-11-06S-3/ARegistration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1625101/000114036118042445/0001140361-18-042445-index.htm
2018-11-19424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1625101/000114036118043418/0001140361-18-043418-index.htm
2018-11-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1625101/000114036118043428/0001140361-18-043428-index.htm
2018-11-21FWPFiling under Securities Act Rules 163/433 of free writing prospectuseshttps://www.sec.gov/Archives/edgar/data/1625101/000114036118043525/0001140361-18-043525-index.htm
2018-11-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1625101/000114036118043530/0001140361-18-043530-index.htm
2020-04-06S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1625101/000114036120008052/0001140361-20-008052-index.htm
2020-04-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1625101/000114036120008055/0001140361-20-008055-index.htm
2020-04-14S-3/ARegistration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1625101/000114036120008801/0001140361-20-008801-index.htm
2020-04-14CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1625101/000114036120008803/0001140361-20-008803-index.htm
2020-04-21S-3/ARegistration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1625101/000114036120009370/0001140361-20-009370-index.htm
2020-04-22CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1625101/000114036120009444/0001140361-20-009444-index.htm
2020-04-24CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1625101/000114036120009751/0001140361-20-009751-index.htm
2020-05-01S-3/ARegistration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1625101/000114036120010389/0001140361-20-010389-index.htm
2020-05-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1625101/000114036120010391/0001140361-20-010391-index.htm
2020-05-07S-3/ARegistration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1625101/000114036120010899/0001140361-20-010899-index.htm
2020-05-07CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1625101/000114036120010903/0001140361-20-010903-index.htm
2020-05-07S-3/ARegistration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1625101/000114036120010963/0001140361-20-010963-index.htm
2020-05-07CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1625101/000114036120010979/0001140361-20-010979-index.htm
2020-05-14424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1625101/000114036120011662/0001140361-20-011662-index.htm
2020-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1625101/000114036120011669/0001140361-20-011669-index.htm
2020-06-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1625101/000114036120013329/0001140361-20-013329-index.htm
2020-06-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1625101/000114036120013997/0001140361-20-013997-index.htm
2018-05-01SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1625101/000117494718000701/0001174947-18-000701-index.htm
2020-02-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1625101/000119312520035994/0001193125-20-035994-index.htm
2018-03-283/AInitial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1625101/000120919118021890/0001209191-18-021890-index.htm
2018-03-285Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1625101/000120919118021891/0001209191-18-021891-index.htm
2018-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1625101/000120919118030347/0001209191-18-030347-index.htm
2018-05-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1625101/000120919118033146/0001209191-18-033146-index.htm
2018-05-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1625101/000120919118033150/0001209191-18-033150-index.htm
2018-05-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1625101/000120919118033152/0001209191-18-033152-index.htm
2018-05-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1625101/000120919118033155/0001209191-18-033155-index.htm
2018-05-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1625101/000120919118033158/0001209191-18-033158-index.htm
2018-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1625101/000120919118035292/0001209191-18-035292-index.htm
2018-12-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1625101/000120919118062920/0001209191-18-062920-index.htm
2019-01-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1625101/000120919119003029/0001209191-19-003029-index.htm
2019-01-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1625101/000120919119003033/0001209191-19-003033-index.htm
2019-01-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1625101/000120919119003036/0001209191-19-003036-index.htm
2019-01-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1625101/000120919119003039/0001209191-19-003039-index.htm
2019-01-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1625101/000120919119003042/0001209191-19-003042-index.htm
2019-01-183Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1625101/000120919119004543/0001209191-19-004543-index.htm
2019-03-193Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1625101/000120919119020373/0001209191-19-020373-index.htm
2019-03-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1625101/000120919119020376/0001209191-19-020376-index.htm
2019-05-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1625101/000120919119030882/0001209191-19-030882-index.htm
2019-05-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1625101/000120919119030893/0001209191-19-030893-index.htm
2019-05-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1625101/000120919119030895/0001209191-19-030895-index.htm
2019-05-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1625101/000120919119030896/0001209191-19-030896-index.htm
2019-05-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1625101/000120919119030902/0001209191-19-030902-index.htm
2019-05-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1625101/000120919119031015/0001209191-19-031015-index.htm
2019-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1625101/000120919119034965/0001209191-19-034965-index.htm
2019-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1625101/000120919119034966/0001209191-19-034966-index.htm
2019-11-193Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1625101/000120919119057140/0001209191-19-057140-index.htm
2019-11-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1625101/000120919119057143/0001209191-19-057143-index.htm
2020-05-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1625101/000120919120030672/0001209191-20-030672-index.htm
2020-05-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1625101/000120919120030674/0001209191-20-030674-index.htm
2020-05-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1625101/000120919120030676/0001209191-20-030676-index.htm
2020-05-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1625101/000120919120030680/0001209191-20-030680-index.htm
2020-05-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1625101/000120919120030682/0001209191-20-030682-index.htm
2020-06-113/AInitial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1625101/000120919120036123/0001209191-20-036123-index.htm
2020-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1625101/000120919120037223/0001209191-20-037223-index.htm
2020-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1625101/000120919120037225/0001209191-20-037225-index.htm
2020-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1625101/000120919120037230/0001209191-20-037230-index.htm
2020-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1625101/000120919120037234/0001209191-20-037234-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1625101/000120919120037928/0001209191-20-037928-index.htm
2020-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1625101/000120919120038948/0001209191-20-038948-index.htm
2020-08-103Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1625101/000120919120045890/0001209191-20-045890-index.htm
2020-08-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1625101/000120919120045891/0001209191-20-045891-index.htm
2018-03-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1625101/000162510118000014/0001625101-18-000014-index.htm
2018-03-28PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1625101/000162510118000016/0001625101-18-000016-index.htm
2018-04-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1625101/000162510118000018/0001625101-18-000018-index.htm
2018-04-12DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1625101/000162510118000020/0001625101-18-000020-index.htm
2018-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1625101/000162510118000022/0001625101-18-000022-index.htm
2018-05-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1625101/000162510118000024/0001625101-18-000024-index.htm
2018-05-09S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1625101/000162510118000026/0001625101-18-000026-index.htm
2018-05-17CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1625101/000162510118000028/0001625101-18-000028-index.htm
2018-05-22424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1625101/000162510118000030/0001625101-18-000030-index.htm
2018-05-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1625101/000162510118000032/0001625101-18-000032-index.htm
2018-06-188-K12BNotification that a class of securities of successor issuer is deemed to be registered pursuant to section 12(b)https://www.sec.gov/Archives/edgar/data/1625101/000162510118000036/0001625101-18-000036-index.htm
2018-07-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1625101/000162510118000041/0001625101-18-000041-index.htm
2018-07-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1625101/000162510118000043/0001625101-18-000043-index.htm
2018-07-3110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1625101/000162510118000045/0001625101-18-000045-index.htm
2018-10-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1625101/000162510118000048/0001625101-18-000048-index.htm
2018-10-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1625101/000162510118000050/0001625101-18-000050-index.htm
2018-11-0110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1625101/000162510118000052/0001625101-18-000052-index.htm
2018-11-02CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1625101/000162510118000054/0001625101-18-000054-index.htm
2018-11-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1625101/000162510118000056/0001625101-18-000056-index.htm
2018-12-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1625101/000162510118000058/0001625101-18-000058-index.htm
2018-12-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1625101/000162510118000061/0001625101-18-000061-index.htm
2019-01-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1625101/000162510119000002/0001625101-19-000002-index.htm
2019-01-22S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1625101/000162510119000004/0001625101-19-000004-index.htm
2019-02-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1625101/000162510119000006/0001625101-19-000006-index.htm
2019-03-1410-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1625101/000162510119000008/0001625101-19-000008-index.htm
2019-03-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1625101/000162510119000013/0001625101-19-000013-index.htm
2019-04-01DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1625101/000162510119000015/0001625101-19-000015-index.htm
2019-04-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1625101/000162510119000017/0001625101-19-000017-index.htm
2019-05-0310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1625101/000162510119000019/0001625101-19-000019-index.htm
2019-05-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1625101/000162510119000021/0001625101-19-000021-index.htm
2019-05-24SDhttps://www.sec.gov/Archives/edgar/data/1625101/000162510119000023/0001625101-19-000023-index.htm
2019-05-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1625101/000162510119000025/0001625101-19-000025-index.htm
2019-08-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1625101/000162510119000027/0001625101-19-000027-index.htm
2019-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1625101/000162510119000029/0001625101-19-000029-index.htm
2019-09-10CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1625101/000162510119000031/0001625101-19-000031-index.htm
2019-09-1110-Q/AQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1625101/000162510119000033/0001625101-19-000033-index.htm
2019-09-1110-Q/AQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1625101/000162510119000035/0001625101-19-000035-index.htm
2019-11-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1625101/000162510119000037/0001625101-19-000037-index.htm
2019-11-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1625101/000162510119000039/0001625101-19-000039-index.htm
2019-12-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1625101/000162510119000041/0001625101-19-000041-index.htm
2020-03-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1625101/000162510120000009/0001625101-20-000009-index.htm
2020-03-1610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1625101/000162510120000011/0001625101-20-000011-index.htm
2020-03-16S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1625101/000162510120000013/0001625101-20-000013-index.htm
2020-03-3110-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1625101/000162510120000015/0001625101-20-000015-index.htm
2020-04-14DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1625101/000162510120000019/0001625101-20-000019-index.htm
2020-05-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1625101/000162510120000025/0001625101-20-000025-index.htm
2020-05-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1625101/000162510120000027/0001625101-20-000027-index.htm
2020-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1625101/000162510120000031/0001625101-20-000031-index.htm
2020-05-29SDhttps://www.sec.gov/Archives/edgar/data/1625101/000162510120000034/0001625101-20-000034-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1625101/000162510120000036/0001625101-20-000036-index.htm
2020-08-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1625101/000162510120000039/0001625101-20-000039-index.htm
2020-08-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1625101/000162510120000041/0001625101-20-000041-index.htm
2020-08-14S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1625101/000162510120000044/0001625101-20-000044-index.htm
2020-08-19CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1625101/000162510120000046/0001625101-20-000046-index.htm
2018-05-21EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1625101/999999999518001297/9999999995-18-001297-index.htm
2018-11-06EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1625101/999999999518002817/9999999995-18-002817-index.htm
2020-05-08EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1625101/999999999520001092/9999999995-20-001092-index.htm
2020-08-21EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1625101/999999999520002226/9999999995-20-002226-index.htm

Pulse Biosciences, Inc (PLSE) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Pulse Biosciences, Inc (PLSE). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 4965%
Institutional Ownership: 1168%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-06-17Maky ZanganehDirectorBuy7,950.007.0155,729.50105,574.00https://www.sec.gov/Archives/edgar/data/1625101/000120919120037928/0001209191-20-037928-index.htm
2020-06-23Maky ZanganehDirectorBuy1,193.0010.7012,767.13106,767.00https://www.sec.gov/Archives/edgar/data/1625101/000120919120038948/0001209191-20-038948-index.htm
2018-05-11ROBERT W DUGGANDirectorBuy21,353.0023.16494,535.485,862,422.00https://www.sec.gov/Archives/edgar/data/1625101/000120919118030347/0001209191-18-030347-index.htm